(Q35783724)

10 August 2017

1 reference

title

Migraine headache misconceptions: barriers to effective care (English)

1 reference

10 August 2017

1 reference

1 reference

Richard Wenzel

1

1 reference

10 August 2017

Marcus Dortch

2

1 reference

10 August 2017

Roger Cady

3

1 reference

10 August 2017

Jennifer H Lofland

4

1 reference

10 August 2017

Seymour Diamond

5

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

24

1 reference

10 August 2017

issue

5

1 reference

10 August 2017

page(s)

638-648

1 reference

Migraine diagnosis and treatment: results from the American Migraine Study II.

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

Quality-of-life differences between patients with episodic and transformed migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

Do butalbital-containing products have a role in the management of migraine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

Should butalbital-containing analgesics be banned? Yes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

Over-the-counter drugs for acute migraine attacks: literature review and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

Brainstem activation specific to migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

Migraine--current understanding and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

The periaqueductal grey matter modulates trigeminovascular input: a role in migraine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

Primary headaches: a convergence hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

Treatment of migraine with rizatriptan: when to take the medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

Within-patient early versus delayed treatment of migraine attacks with almotriptan: the sooner the better

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

Premonitory symptoms in migraine: an electronic diary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

Variable participation of 5-HT1-like receptors and 5-HT2 receptors in serotonin-induced contraction of human isolated coronary arteries. 5-HT1-like receptors resemble cloned 5-HT1D beta receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

5-Hydroxytryptamine contracts human coronary arteries predominantly via 5-HT2 receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

Effect of subcutaneous sumatriptan, a selective 5HT1 agonist, on the systemic, pulmonary, and coronary circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

Prospective large-scale study of the tolerability of subcutaneous sumatriptan injection for acute treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

Tolerability and efficacy of naratriptan tablets with long-term treatment (6 months). Naratriptan Long-term Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice g

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

Establishing a standard of speed for assessing the efficacy of the serotonin(1B/1D) agonists (triptans).

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

Differentiating the efficacy of 5-HT(1B/1D) agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

What matters is not the differences between triptans, but the differences between patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

Triptans are all different

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

Diagnostic lessons from the spectrum study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

2000 Wolfe Award. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

Sinus headache or migraine? Considerations in making a differential diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

Changes in resource use and outcomes for patients with migraine treated with sumatriptan: a managed care perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

Healthcare resource and lost labour costs of migraine headache in the US.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

Workplace productivity. A review of the impact of migraine and its treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

The economic burden of migraine to society

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

Burden of migraine in the United States: disability and economic costs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

Undiagnosed migraine headaches. A comparison of symptom-based and reported physician diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

An update on the epidemiology of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

A review of health-related workplace productivity loss instruments

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

Societal perspective on the burden of migraine in The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

Validation of a migraine work and productivity loss questionnaire for use in migraine studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

The migraine work and productivity loss questionnaire: concepts and design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

The Work Limitations Questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

A six-item short-form survey for measuring headache impact: the HIT-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

Cost-effectiveness analysis of stratified versus stepped care strategies for acute treatment of migraine: The Disability in Strategies for Care (DISC) Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

Medication-induced headache: overview and systematic review of therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

The Work Limitations Questionnaire's validity and reliability among patients with osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

Treatment of Mild Headache in Disabled Migraine Sufferers: Results of the Spectrum Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.6.638.34751

10.1592/PHCO.24.6.638.34751

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference